Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02BAE
|
|||
| Former ID |
DIB008587
|
|||
| Drug Name |
Synthetic conjugated estrogen
|
|||
| Synonyms |
Bijuva; Bithena; DR-2041; SCE-A Vaginal Cream; Synthetic conjugated estrogen (cream, vulvovaginal atrophy); Synthetic conjugated estrogen (cream, vulvovaginal atrophy), Teva
Click to Show/Hide
|
|||
| Indication | Vaginal disease [ICD-11: GA1Y] | Phase 3 | [1] | |
| Company |
Duramed Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00361569) A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy. U.S. National Institutes of Health. | |||
| REF 2 | Relief of hot flushes with new plant-derived 10-component synthetic conjugated estrogens. Obstet Gynecol. 2004 Feb;103(2):245-53. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.